Keep checking for updates and new content.

Treatments

Updated Guideline on Brachytherapy in Prostate Cancer

May 7, 2017

The Cancer Care Ontario guideline on brachytherapy for patients with prostate cancer was updated to account for new evidence. Read the article here.

Read the article or watch the video →

15-year metastasis-free survival in men on active surveillance in The Netherlands

May 7, 2017

According to new data reported at the annual meeting of the European Association of Urology in London, active surveillance of men diagnosed with low-risk prostate cancer was not associated with an elevated risk for metastatic disease at 15 years of follow-up. Read the article here.

Read the article or watch the video →

Finding common ground on how “best” to treat localized prostate cancer, and what to tell patients

May 7, 2017

With the goals of working together more collaboratively and to provide higher quality information for patients at the time of decision-making, a prostate cancer community partnership consensus (PCPC) panel was formed among six partnering centers in the Greater Toronto Area. Read the article here.

Read the article or watch the video →

Video: “The Prostate Gland and Testosterone: relationship, importance to overall health, and the impact of prostate cancer and treatment on one’s health”

May 5, 2017

March 2017 Awareness Night The Prostate Gland and Testosterone: relationship, importance to overall health, and the impact of prostate cancer and treatment on one’s health Dr. Joseph R. LaBossiere, BMSc, MD, MSc, FRCSC Reconstructive Urology Fellow, Sunnybrook Health Sciences Centre             CLICK ON THE ARROW TO START THE VIDEO The […]

Read the article or watch the video →

Prostate Cancer Study Details Value of Treatments

April 9, 2017

A new study offers important information to men who are facing difficult decisions about how to treat prostate cancer in its early stages, or whether to treat it at all. Researchers followed patients for 10 years and found no difference in death rates between men who were picked at random to have surgery or radiation, […]

Read the article or watch the video →

Biolyse Pharma stymied in effort to make cheaper version of pricey prostate cancer drug

April 9, 2017

A small Canadian company has waded into a U.S. drug price controversy by offering to make an expensive prostate cancer drug for a fraction of the price. Right now Xtandi costs U.S. patients as much as $129,000 US a year, or about $90 per pill. St. Catharines, Ont.-based Biolyse Pharma says it can make the […]

Read the article or watch the video →

Prostate Cancer Treatment Breakthrough

April 9, 2017

Scientists with Deakin’s School of Medicine have found that, when coupled with the milk protein lactoferrin, the chemotherapy drug Doxorubicin (Dox) can be delivered directly into the nucleus of prostate cancer cells and will kill them cells as well as drug resistant cancer stem cells, without any side-effects. Read the article here.

Read the article or watch the video →

What influences opting out of active surveillance?

April 9, 2017

A man’s race/ethnicity might influence decision-making regarding opting for active treatment as well as undergoing serial biopsies during active surveillance, according to a recent study. Read the article here.

Read the article or watch the video →

Treating prostate cancer with precision

April 9, 2017

The treatment, called focal needle ablation, makes use of a needle that can freeze (cryoablation) or use heat (radiofrequency ablation) to destroy cancer cells. Read the article here.

Read the article or watch the video →

Psychological Effects From ADT a Growing Challenge in Prostate Cancer

February 19, 2017

Androgen-deprivation therapy (ADT) can be associated with significant psychological effects in patients with prostate cancer. Additionally, these side effects—which include depression, Alzheimer disease, and coronary disease—are often under-reported by patients. Read the article here.

Read the article or watch the video →